The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

March 28, 2022

Study Completion Date

March 28, 2022

Conditions
Diabetes Mellitus, Insulin-DependentDiabetes
Interventions
OTHER

Wearing smartwatch and continous glucose sensor

Patients will be wearing a smartwatch and a continuous glucose meter (CGM) over a maximum duration of 3 months in an outpatient setting.

Trial Locations (1)

Unknown

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern

All Listed Sponsors
collaborator

ETH Zurich

OTHER

collaborator

University of St.Gallen

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04689685 - The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes | Biotech Hunter | Biotech Hunter